Term ends no later than Nov 1, 2027 · Medium confidence
20-year base term ends Nov 28, 2026
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Nov 28, 2006
Nov 1, 2027
Sep 20, 2011
This patent's term runs 338 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 28, 2006, when this application, 11/605,700, was filed | Nov 28, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +338 days, USPTO patent term adjustment record | Nov 1, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Nov 1, 2027 | Medium confidence |
This family
| US 8,022,054 | this patent no later than Nov 2027 | no later than Nov 2027 |
| US 8,367,651 | In force Nov 2026 | Nov 2026 |
| US 8,318,714 | In force Nov 2031 | Nov 2031 |
| US 9,056,116 | In force no later than Nov 2026 | no later than Nov 2026 |
| US 8,618,087 | In force no later than Nov 2026 | no later than Nov 2026 |
| US 9,029,355 | In force Nov 2026 | Nov 2026 |
| US 9,452,176 | In force Nov 2026 | Nov 2026 |
| US 11,071,740 | In force Nov 2026 | Nov 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 28, 2006 Reel 18638, frame 982 | Shaw, Kenneth; Zhang, Mingbao | Marinus Pharmaceuticals | Assignment of Assignor's Interest |
| Oct 3, 2012 Reel 29071, frame 854 | Shaw, Kenneth; Zhang, Mingbao | Marinus Pharmaceuticals | Assignment of Assignor's Interest |
| May 11, 2021 Reel 56206, frame 266 | Marinus Pharmaceuticals, Inc. | Oaktree Fund Administration, LLC | Security Interest |
| Oct 28, 2022 Reel 61580, frame 171 | Marinus Pharmaceuticals, Inc. | Sagard Healthcare Royalty Partners, LP | Security Interest |
| Feb 13, 2025 Reel 70204, frame 35 | Sagard Healthcare Partners Funding Company SPE 1, LLC | Marinus Pharmaceuticals, Inc. | Release of Security Interest |
| Feb 20, 2025 Reel 70278, frame 496 | Oaktree Fund Administration, LLC | Marinus Pharmaceuticals, Inc. | Release of Security Interest |
| May 15, 2025 Reel 71128, frame 703 | Marinus Pharmaceuticals, Inc. | Immedica Pharma US Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 1, 2027. We will not guess the cap.